Exercise therapy and comorbidity in osteoarthritis of the hip or knee: case series

Exercise therapy and comorbidity in osteoarthritis of the hip or knee: case series - Comorbidity and exercise therapy in osteoarthritis: case studies

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON34798

Enrollment

Registered

2010-03-25

Start date

2010-04-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoarthritis

Interventions

Prior to treatment, the goals for the treatment are established which have to be relevant for the patient. Examples of frequently established goals are: (1) increasing walking distance (2) improving

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - diagnosis of knee OA according to the clinical ACR criteria (33), i.e.: knee pain and at least three of the following six: age > 50 years, morning stiffness 50 years - at least one of the following comorbidities (diagnosed by a physician): coronary heart diseases, heart failure, hypertension, diabetes type 2, obesitas, chronic obstructive pulmonary diseases (COPD), osteoarthritis of the foot and hand, chronic pain, chronic low back pain, depression, visual/hearing impairments and chronic cystitis

Exclusion criteria

Exclusion criteria: - Indication for knee or hip prothesis - Refusal to sign informed consent - Not able to come to the centre for treatment - Insufficient control over the Dutch language

Design outcomes

Primary

Measure	Time frame
A process evaluation and treatment evaluation are performed in this study. The process evaluation is based on the framework described by van Schenkman et al. 2006. We will evaluate which adaptations have been made to the standard treatment protocol due to co-morbidity. The form will be filled in by the therapist at the start and at the end of the treatment process. Additionally, after each treatment session, a registration form will be completed by the therapist, detailing specific changes that were made concerning that session. At the end of the treatment process, the therapist will be interviewed to identify strengths and weaknesses in the treatment protocol and possible areas of improvement. The patient will also be interviewed to obtain information about treatment satisfaction, as well as possible areas of improvement in the treatment process. Primary outcome measures to evaluate treatment success are the Time Get Up and Go Test and the physical functioning scale of the Western Ontario and MacMasters Universities Osteoarthritis Index (WOMAC-pf).	—

Measure

Time frame

A process evaluation and treatment evaluation are performed in this study. The process evaluation is based on the framework described by van Schenkman et al. 2006. We will evaluate which adaptations have been made to the standard treatment protocol due to co-morbidity. The form will be filled in by the therapist at the start and at the end of the treatment process. Additionally, after each treatment session, a registration form will be completed by the therapist, detailing specific changes that were made concerning that session. At the end of the treatment process, the therapist will be interviewed to identify strengths and weaknesses in the treatment protocol and possible areas of improvement. The patient will also be interviewed to obtain information about treatment satisfaction, as well as possible areas of improvement in the treatment process. Primary outcome measures to evaluate treatment success are the Time Get Up and Go Test and the physical functioning scale of the Western Ontario and MacMasters Universities Osteoarthritis Index (WOMAC-pf).

—

Secondary

Measure	Time frame
Secundary parameters in the treatment evaluation are the 6-minute walking test, stair climbing test, knee joint proprioception, flexion and extension knee muscle strength, perceived global effect (7-point Likert scale), pain (0-10 NRS), stiffness (WOMAC), fatigue (VAS) en patient specific complaints checklist (PSK)	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)